AFP and hepatocellular carcinoma: Our findings align with existing literature in suggesting that elevated mMDSCs levels are indicative of aggressive HCC phenotypes, including advanced BCLC stages, elevated serum AFP and PIVKA‐II levels, and the presence of portal vein tumor thrombus and metastases.2, 6, 22, 23, 24